Using Artificial Intelligence to Interpret Clinical Flow Cytometry Datasets for Automated Disease Diagnosis and/or Monitoring

© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature..

Flow cytometry (FC) is routinely used for hematological disease diagnosis and monitoring. Advancement in this technology allows us to measure an increasing number of markers simultaneously, generating complex high-dimensional datasets. However, current analytic software and methods rely on experienced analysts to perform labor-intensive manual inspection and interpretation on a series of 2-dimensional plots via a complex, sequential gating process. With an aggravating shortage of professionals and growing demands, it is very challenging to provide the FC analysis results in a fast, accurate, and reproducible way. Artificial intelligence has been widely used in many sectors to develop automated detection or classification tools. Here we describe a type of machine learning method for developing automated disease classification and residual disease monitoring on clinical flow datasets.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:2779

Enthalten in:

Methods in molecular biology (Clifton, N.J.) - 2779(2024) vom: 01., Seite 353-367

Sprache:

Englisch

Beteiligte Personen:

Wang, Yu-Fen [VerfasserIn]
Li, Jeng-Lin [VerfasserIn]
Lee, Chi-Chun [VerfasserIn]
Wallace, Paul K [VerfasserIn]
Ko, Bor-Sheng [VerfasserIn]

Links:

Volltext

Themen:

Acute myeloid leukemia
Artificial intelligence
Automated classification
Flow cytometry
Journal Article
Machine learning

Anmerkungen:

Date Completed 27.03.2024

Date Revised 27.03.2024

published: Print

Citation Status MEDLINE

doi:

10.1007/978-1-0716-3738-8_16

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM37016363X